Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic

• Autorzy: Dworakowska D. , Grossman A.B.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

COVID-19; renin-angiotensin system; angiotensin converting enzyme; angiotensis; aldosterone; hypertension; treatment; angiotensin II; mortality; patient; coexistence; severe acute respiratory syndrome

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 2
• Opis fizyczny: p.173-178,fig.,ref.

Twórcy

autor

Dworakowska D.

• Department of Hypertension and Diabetes, Medical University of Gdansk, 7C Debinki Street, 80-952 Gdansk, Poland
• Guys Richard Dimbleby Department of Cancer Research, Kings College London, London, U.K.
• London International Clinic, London, U.K.

autor

Grossman A.B.

• Centre for Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, U.K.
• Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, U.K.

Identyfikatory

DOI

10.26402/jpp.2020.2.01